August 2, 2013 |
The U.S. Food and Drug Administration has announced new regulations for the labeling of "gluten-free" foods, saying standardization is necessary to protect consumers with celiac disease. The new federal regulation requires that all foods labeled "gluten-free," "no gluten," "free of gluten" and "without gluten" must all contain less than 20 parts per million of gluten. "Adherence to a gluten-free diet is the key to treating celiac disease, which can be very disruptive to everyday life," said Dr. Margaret A. Hamburg, FDA commissioner.
July 31, 2013 |
Nova Diabetes Care is recalling up to 62 million glucose test strips that show an incorrect high sugar level reading, the U.S. Food and Drug Administration said Wednesday. The voluntary recall was announced by the company Friday for products sold as under the brand names of Max Blood Glucose Test Strips and Nova Max Plus Glucose Meter Kits. The strips were sold in the U.S. and in 13 countries and Puerto Rico, the FDA said in statement. Top 10 riskiest industries for investors The federal agency warned that the inaccurate reading could cause users to administer an incorrect dosage error, leading some to seek immediately medical attention.
July 24, 2013 |
Menthol cigarette smokers might be forced to switch to regular cigarettes or be motivated to quit the habit as the Food and Drug Administration focuses new attention on the mint-flavored tobacco product. Based on new research that argues menthol cigarettes are more addictive than regular cigarettes, the FDA has announced a new round of efforts to regulate the use of menthol as a tobacco additive and opened a 60-day period of public comment . As of Wednesday afternoon, none had been received.
July 23, 2013 |
Mentholated cigarettes are more appealing to new smokers, more addictive to longtime smokers and pose a greater threat to the public's health than does unflavored tobacco, the U.S. Food and Drug Administration said Tuesday as it announced a new round of efforts to regulate the use of menthol as a tobacco additive. In releasing a comprehensive review of research on menthol's effects on smokers, the agency conceded that tobacco flavored with peppermint oil extract likely poses no greater disease risk to smokers than does unflavored tobacco.
July 15, 2013 |
The U.S. Food and Drug Administration has proposed limiting how much arsenic can be in apple juice sold to Americans. The agency is acting in the wake of a Consumer Reports analysis on levels of the potentially poisonous metal in the popular fruit drink. The FDA stressed that it is confident that apple juice is safe to drink, but it nonetheless said it would limit arsenic levels in apple juice to 10 parts per billion -- the same level set...
July 8, 2013 |
In a recent post , I noted the Catch-22 that the Supreme Court insists Congress created with its fast-track approvals for generic drugs. Those who are injured by a brand-name drug can win compensation from the manufacturer if they can show the drug was unreasonably dangerous or that its warning label didn't disclose the risks properly. But those injured by a generic medicine can't hold the manufacturer liable as long as the drug maker used the same active ingredients and displayed the same warnings as the brand-name drug.
July 3, 2013 |
Arsenic is one dangerous pollutant that can occur naturally (though it also can be a byproduct of pesticide use or certain kinds of mining), usually ingested via water. In Nepal and other impoverished areas of Asia where arsenic levels are high, low-tech water filters make a huge difference - a jar filled with rusty nails and sand. The ferrous oxide in the nails binds to the arsenic; particles then are filtered out in the sand. That works for households but not for rice fields, where immense amounts of water are used.
June 28, 2013 |
Is it hot in here, or am I just depressed? For many menopausal women, hot flashes are just depressing. And depression, which affects at least one in four women ages 40 to 59, can intensify the misery of hot flashes, as well. No surprise, then, that a pharmaceutical company came up with the idea to market an antidepressant for treatment of vasomotor symptoms, a.k.a. hot flashes. And on Friday, bucking the recommendation of its advisory committee on reproductive health drugs, the Food & Drug Administration approved the idea.
June 26, 2013 |
The Securities and Exchange Commission accused a Burbank medical imaging device company and its chief executive of fraud for allegedly misleading investors about the Food and Drug Administration's views of one of its products. In a lawsuit filed Tuesday in federal court in Los Angeles, the SEC said Imaging3 Inc. and its founder and chief executive, Dean Janes, made false statements about the company's chances of gaining FDA approval of a three-dimensional scanner used in medical diagnosis.